143 related articles for article (PubMed ID: 20633100)
1. Liver regeneration and tumour stimulation: implications of the renin-angiotensin system.
Koh SL; Ager EI; Christophi C
Liver Int; 2010 Nov; 30(10):1414-26. PubMed ID: 20633100
[TBL] [Abstract][Full Text] [Related]
2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
3. Liver regeneration stimulates tumor metastases.
Harun N; Nikfarjam M; Muralidharan V; Christophi C
J Surg Res; 2007 Apr; 138(2):284-90. PubMed ID: 17254608
[TBL] [Abstract][Full Text] [Related]
4. Blockade of the renin-angiotensin system improves the early stages of liver regeneration and liver function.
Koh SL; Ager E; Malcontenti-Wilson C; Muralidharan V; Christophi C
J Surg Res; 2013 Jan; 179(1):66-71. PubMed ID: 23110972
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and treatment of colorectal liver metastases - workflow].
Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
[TBL] [Abstract][Full Text] [Related]
6. Resection and local therapy for liver metastases.
Schlag PM; Benhidjeb T; Stroszczynski C
Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):299-317. PubMed ID: 11969240
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
[TBL] [Abstract][Full Text] [Related]
8. Liver regeneration and its impact on post-hepatectomy metastatic tumour recurrence.
Paschos KA; Bird NC
Anticancer Res; 2010 Jun; 30(6):2161-70. PubMed ID: 20651365
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting the renin-angiotensin system: why and in which patients.
Berra K; Miller NH
J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival and disease recurrence following portal vein embolisation prior to major hepatectomy for colorectal metastases.
Pamecha V; Glantzounis G; Davies N; Fusai G; Sharma D; Davidson B
Ann Surg Oncol; 2009 May; 16(5):1202-7. PubMed ID: 19130138
[TBL] [Abstract][Full Text] [Related]
11. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases.
Laurent C; Sa Cunha A; Couderc P; Rullier E; Saric J
Br J Surg; 2003 Sep; 90(9):1131-6. PubMed ID: 12945082
[TBL] [Abstract][Full Text] [Related]
12. Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma.
Barone M; Viggiani MT; Losurdo G; Principi M; Leo AD
World J Gastroenterol; 2019 May; 25(20):2524-2538. PubMed ID: 31171895
[TBL] [Abstract][Full Text] [Related]
13. Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1cm rule.
Hamady ZZ; Cameron IC; Wyatt J; Prasad RK; Toogood GJ; Lodge JP
Eur J Surg Oncol; 2006 Jun; 32(5):557-63. PubMed ID: 16580811
[TBL] [Abstract][Full Text] [Related]
14. Recent changes in the landscape of combination RAS blockade.
Epstein BJ; Smith SM; Choksi R
Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
[TBL] [Abstract][Full Text] [Related]
15. Rationale for combining blockers of the renin-angiotensin system.
Azizi M; Wuerzner G
Semin Nephrol; 2007 Sep; 27(5):544-54. PubMed ID: 17868792
[TBL] [Abstract][Full Text] [Related]
16. On target to dual block RAS?
Papadopoulos DP; Papademetriou V; Makris TK
Angiology; 2009 Dec-2010 Jan; 60(6):739-49. PubMed ID: 19144653
[TBL] [Abstract][Full Text] [Related]
17. Blockade of the renin-angiotensin system inhibits growth of colorectal cancer liver metastases in the regenerating liver.
Koh SL; Ager EI; Costa PL; Malcontenti-Wilson C; Muralidharan V; Christophi C
Clin Exp Metastasis; 2014 Apr; 31(4):395-405. PubMed ID: 24442969
[TBL] [Abstract][Full Text] [Related]
18. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.
Böger CA; Götz AK; Krüger B; Hösl M; Schmitz G; Riegger GA; Krämer BK
Eur J Med Res; 2005 Apr; 10(4):161-8. PubMed ID: 15946912
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
Grothusen A; Divchev D; Luchtefeld M; Schieffer B
Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
[TBL] [Abstract][Full Text] [Related]
20. Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases--activation of cell invasion and migration pathways.
Man K; Ng KT; Lo CM; Ho JW; Sun BS; Sun CK; Lee TK; Poon RT; Fan ST
Liver Transpl; 2007 Dec; 13(12):1669-77. PubMed ID: 18044786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
